VAM
ASTX

Visium Asset Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Visium Asset Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-187,356
Closed -$1.59M – 1077
2013
Q3 		$1.59M Buy
+187,356
New +$1.19M 0.04% 335

Visium Asset Management's ASTX Position: Q4 2013 in Review

Visium Asset Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 187,356 shares — an estimated $1.59M sold.

Visium Asset Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $1.59M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Visium Asset Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Visium Asset Management sold 187,356 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $1.59M.
  • Visium Asset Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Visium Asset Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $1.59M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.